Does ATENOLOL Cause Basal cell carcinoma? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Basal cell carcinoma have been filed in association with ATENOLOL (Atenolol and Chlorthalidone). This represents 0.1% of all adverse event reports for ATENOLOL.
14
Reports of Basal cell carcinoma with ATENOLOL
0.1%
of all ATENOLOL reports
0
Deaths
8
Hospitalizations
How Dangerous Is Basal cell carcinoma From ATENOLOL?
Of the 14 reports, 8 (57.1%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATENOLOL. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ATENOLOL Cause?
Drug ineffective (1,231)
Hypotension (1,121)
Bradycardia (942)
Completed suicide (928)
Dyspnoea (791)
Toxicity to various agents (742)
Nausea (652)
Fatigue (649)
Off label use (638)
Dizziness (632)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which ATENOLOL Alternatives Have Lower Basal cell carcinoma Risk?
ATENOLOL vs ATENOLOL\CHLORTHALIDONE
ATENOLOL vs ATEZOLIZUMAB
ATENOLOL vs ATLANTIC SALMON OIL
ATENOLOL vs ATOGEPANT
ATENOLOL vs ATOMOXETINE